Study of Monoclonal Antibody Nirsevimab Against Respiratory Syncytial Virus (RSV) in Participants up to 24 Months of Age in India
Clinical trial NCT07109297 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07109297
- Sponsor
- Sanofi
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-31
- Primary completion
- 2026-06-30
- Enrollment
- 110
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.